Original Program Date: June 20, 2018
CME/CE Expiration Date: June 30, 2019
Estimated Program Time: 1 hour, 5 minutes
This activity is jointly provided by Medical Education Resources and the National Stroke Association.
*Download the Spasticity Treatment Dialogue Tool for patients and their heathcare providers.
This program provides an engaging discussion for healthcare professionals on the use of different spasticity diagnostic tools, the latest evidence on spasticity treatments, and providing the right treatment for each patient based on their individual goals and needs.
Through participation in this activity, learners should be able to:
- Define Spasticity and how it affects stroke survivors
- Discuss effectiveness of common diagnostic tools
- Explain treatment options
- Apply and evaluate treatment option selected for each patient
Spasticity: Latest Evidence on Treatment and Patient Outcomes is for healthcare professionals specializing in neurology and emergency medicine. This activity is also appropriate for other healthcare professionals who care for stroke patients and may have the opportunity to educate peers within their facilities.
Continuing Medical Education Credit
Medical Education Resources is accredited by the Accreditation Council for Continuing Medical Education as a provider of continuing medical education for physicians.
Medical Education Resources designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1 contact hour of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.
This activity is designed for individual participation and each individual must register for the event. There are no fees for participation in this activity.
Content Developed and Presented By
Dr. Gerard Francisco, MD
Chief Medical Officer at TIRR Memorial Hermann/Memorial Hermann Rehabilitation Network
Professor and Chairman of Physical Medicine and Rehabilitation at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth)
Adjunct Professor, Department of Physical Medicine and Rehabilitation at Baylor College of Medicine
Chair, Rehabilitation Clinical Practice Committee at Memorial Hermann Hospital System
Dr. Richard D. Zorowitz, MD
Attending Physician, Outpatient Physician Services at MedStar National Rehabilitation Network
Disclosure of Conflict of Interest
Medical Education Resources (MER) ensures balance, independence, objectivity, and scientific rigor in all its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of a commercial interest.
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity.
|Name of Faculty||Reported Financial Relationship|
|Richard Zorowitz, MD||No financial relationship to disclose.|
|Gerard Francisco, MD||Grants/Research Support, Consulting Fees: Allergan, Merz, Ipsen, Ottobock, MicroTransponder|
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Content Manager||Reported Financial Relationship|
|Medical Education Resources||No financial relationships to disclose|
|Staci Blinn, National Stroke Association||No financial relationships to disclose|
|Anna Taylor, National Stroke Association||No financial relationships to disclose|
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources (MER), National Stroke Association, and/or Stryker. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Medical Education Resources, National Stroke Association and/or Stryker. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Spasticity: Latest Evidence on Treatment and Patient Outcomes is supported by educational grants from Merz North America, Inc., Piramal Critical Care, and Allergan Inc.